Platelet adhesion and activation mechanisms in arterial thrombosis and ischaemic stroke
Platelet adhesion, activation and aggregation on the exposed subendothelial extracellular
matrix (ECM) are essential for haemostasis, but may also lead to occlusion of diseased …
matrix (ECM) are essential for haemostasis, but may also lead to occlusion of diseased …
Functional significance of the platelet immune receptors GPVI and CLEC-2
Although platelets are best known for their role in hemostasis, they are also crucial in
development, host defense, inflammation, and tissue repair. Many of these roles are …
development, host defense, inflammation, and tissue repair. Many of these roles are …
Platelets and platelet adhesion molecules: novel mechanisms of thrombosis and anti-thrombotic therapies
Platelets are central mediators of thrombosis and hemostasis. At the site of vascular injury,
platelet accumulation (ie adhesion and aggregation) constitutes the first wave of hemostasis …
platelet accumulation (ie adhesion and aggregation) constitutes the first wave of hemostasis …
Ischaemic stroke: a thrombo‐inflammatory disease?
B Nieswandt, C Kleinschnitz… - The Journal of physiology, 2011 - Wiley Online Library
Ischaemic stroke is a leading cause of death and disability worldwide. The complex cellular
interactions leading from thromboembolic vessel occlusion to infarct development within the …
interactions leading from thromboembolic vessel occlusion to infarct development within the …
[HTML][HTML] The role of CLEC-2 and its ligands in thromboinflammation
D Meng, M Luo, B Liu - Frontiers in immunology, 2021 - frontiersin.org
C-type lectin-like receptor 2 (CLEC-2, also known as CLEC-1b) is expressed on platelets,
Kupffer cells and other immune cells, and binds to various ligands including the mucin-like …
Kupffer cells and other immune cells, and binds to various ligands including the mucin-like …
Platelet GPVI: a target for antithrombotic therapy?!
S Dütting, M Bender, B Nieswandt - Trends in pharmacological sciences, 2012 - cell.com
Platelet activation is a key step in the pathogenesis of ischemic cardio-and cerebrovascular
diseases, which represent the leading causes of death and severe disability worldwide …
diseases, which represent the leading causes of death and severe disability worldwide …
[HTML][HTML] Soluble platelet release factors as biomarkers for cardiovascular disease
Platelets are the main players in thrombotic diseases, where activated platelets not only
mediate thrombus formation but also are involved in multiple interactions with vascular cells …
mediate thrombus formation but also are involved in multiple interactions with vascular cells …
The platelet fc receptor, FcγRIIa
J Qiao, M Al‐Tamimi, RI Baker… - Immunological …, 2015 - Wiley Online Library
Human platelets express Fcγ RII a, the low‐affinity receptor for the constant fragment (Fc) of
immunoglobulin (Ig) G that is also found on neutrophils, monocytes, and macrophages …
immunoglobulin (Ig) G that is also found on neutrophils, monocytes, and macrophages …
Glycoprotein VI-novel target in antiplatelet medication
O Borst, M Gawaz - Pharmacology & therapeutics, 2021 - Elsevier
Subendothelial collagen exposed to platelets after rupture of atherosclerotic plaques is the
main trigger of platelet activation und acute arterial thrombotic occlusion leading to …
main trigger of platelet activation und acute arterial thrombotic occlusion leading to …
[HTML][HTML] Mechanical circulatory support is associated with loss of platelet receptors glycoprotein Ibα and glycoprotein VI
P Lukito, A Wong, J Jing, JF Arthur, SF Marasco… - Journal of Thrombosis …, 2016 - Elsevier
Essentials• Relationship of acquired von Willebrand disease (VWD) and platelet dysfunction
is explored.• Patients with ventricular assist devices and on extracorporeal membrane …
is explored.• Patients with ventricular assist devices and on extracorporeal membrane …